Kathryn C. Zoon - 09 Jun 2022 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Brian Millard, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
09 Jun 2022
Net transactions value
-$36,973
Form type
4
Filing time
13 Jun 2022, 16:16:09 UTC
Previous filing
31 May 2022
Next filing
30 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $36,973 -1,173 -5.6% $31.52* 19,654 09 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.